GSK gets FDA approval for Nucala to treat CRSwNP in adults
The FDA approval is supported by data from the SYNAPSE study that assessed the effect of Nucala in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
30 Jul 21
The FDA approval is supported by data from the SYNAPSE study that assessed the effect of Nucala in…
29 Jul 21
Sotrovimab is a SARS-CoV-2 monoclonal antibody intended to treat Covid-19 in adults and adolescents, aged 12 years and…
28 Jul 21
The acquisition includes a portfolio of early-stage oncology assets, including a Phase 1 bispecific antibody for advanced prostate…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Jul 21
The collaboration builds on Regeneron's recent discovery of the relation between rare mutations in the GPR75 gene and…
27 Jul 21
Shingrix is a non-live, recombinant sub-unit adjuvanted vaccine, administered intramuscularly in two doses
27 Jul 21
The acquisition of BioLegend, the largest transaction in PerkinElmer’s history, will expand its existing life science franchise into…
26 Jul 21
Spikevax produced similar level of antibodies in children aged 12 to 17 years, to that observed in young…
26 Jul 21
It is the first regulatory approval for a once-weekly glucagon-like peptide-1 receptor agonist (GLP-1 RA) in the indicated…
23 Jul 21
We look at how, according to industry experts, professionals can look to guidance from the FDA to improve…
23 Jul 21
ARV-471 is currently in Phase 2 studies for the treatment of patients with locally advanced or metastatic ER+/HER2-…